Cadre Holdings, Inc.

Cadre Holdings, Inc.(CDRE)股票分析

$27.050

-0.019 (-0.07%)收盘时

Loading chart…
最高
27.387
开盘
27.220
成交量加权均价
26.84
成交量
643.24K
市值
1.34B
最低
26.090
成交额
17.27M
企业价值/息税折旧摊销前利润(TTM)
12.07

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others.

AI 分析 of Cadre Holdings, Inc. (CDRE)

买入

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

估值指标

Cadre Holdings, Inc.(CDRE)当前预期市盈率为 18.15,5 年平均预期市盈率为 30.24。

预期市盈率

合理
5 年均值 P/E
30.24
当前P/E
18.15
高估
46.23
低估
14.26

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
13.22
当前EV/EBITDA
12.07
高估
15.05
低估
11.39

预期市销率

低估
5 年均值 P/S
2.01
当前P/S
1.43
高估
2.33
低估
1.68

Alphio AI 对 CDRE 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%CDRE

$34.59

情景价格

基

基准

基准 · 50%CDRE

$30.16

情景价格

悲

悲观

悲观 · 25%CDRE

$29.75

情景价格

持有 CDRE 的大户

G

Greenhouse Funds LLLP

+ 持有CDRE

+4.62%

3个月收益率

事件时间线

2026-08-05 (ET)

16:30:00

Company Reports Q2 Revenue of $207.1M, Exceeding Expectations

16:30:00

Cadre Raises 2026 Sales Guidance to $749-$769 Million

2026-06-02 (ET)

16:20:00

Cadre Holdings Subsidiary Safariland Wins $61 Million FBI Contract

2026-05-11 (ET)

16:30:00

Cadre Reports Q1 Revenue of $155.4M, Exceeds Expectations

16:30:00

Company Confirms FY26 Adjusted EBITDA View of $136M-$141M

资讯

CDRE 常见问题 —— 由 Alphio AI 解答

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others. It operates in the Industrials sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易